GLP-1 ve GIP sınıfı ilaçlar Alzheimer ve Parkinson hastalığında nöroprotektif özelliklere sahiptir.
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
DOI: 10.3389/fnins.2026.1906426PMID: 42666495
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
DOI: 10.3389/fnins.2026.1906426PMID: 42666495
Matrix metalloproteinases (MMPs) in neurodegenerative diseases, an updated overview of the role of MT1-MMP and MT5-MMP in Alzheimer's disease.
DOI: 10.1016/bs.enz.2026.07.004PMID: 42772840
Exercise and Motor Complications in Parkinson's Disease: A Systematic Review and Meta-Analysis.
DOI: 10.1002/mdc3.70766PMID: 42596701
Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson's disease.
DOI: 10.1007/s13105-026-01218-7PMID: 42599550
Prevalence, predictors, and emerging biomarkers for cognitive impairment and neuropsychiatric manifestations in Parkinson's disease in Africa: A systematic review.
DOI: 10.1177/1877718x261479269PMID: 42599715
Sleep-wake control with age and neurodegenerative diseases.
DOI: 10.1016/j.smrv.2026.102352PMID: 42617572
Baicalin and CNS-related diseases: new insights into neuroprotective potentials based on underlying mechanisms.
DOI: 10.1016/j.bbrep.2026.102741PMID: 42633185
Regulation and roles of mammalian mitophagy.
DOI: 10.1038/s41580-026-01012-9PMID: 42601490
Ultraviolet radiation and neurodegeneration: molecular mechanisms underlying dual neuroprotective and neurotoxic effects.
DOI: 10.3389/fncel.2026.1909393PMID: 42661656
Redox-exercise crosstalk in neurodegenerative diseases: mechanistic perspectives on antioxidant interactions with Nrf2-BDNF signaling, autophagy, and mitochondrial plasticity.
DOI: 10.3389/fnut.2026.1850414PMID: 42661679
Glucagon-like peptide-1 receptor agonists and the risk of Parkinson's disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data.
DOI: 10.3389/fendo.2026.1849318PMID: 42661791
Pain and sensory abnormalities in prodromal and early Parkinson's disease: mechanisms, assessment, and clinical implications.
DOI: 10.3389/fpain.2026.1888196PMID: 42676769
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.